Hints and tips:
...It is about balanced interdependencies and it is about reliability.” US Treasury secretary Janet Yellen has floated “friendshoring” as a compromise concept....
...“There is a whole set of basic expectations about how world trade works and those companies have spent decades building models around it.”...
...This limits the size of Merck’s potential market but promises to reassure healthcare providers and insurers that the hefty $12,500 a month US price is worth paying....
...Some analysts think AstraZeneca’s forecasts for MEDI4736 are too optimistic and warn of fierce competition from Bristol-Myers Squibb, Merck & Co, and Roche....
...However, success is far from guaranteed, with more clinical trials to come and intense competition from Bristol-Myers Squibb, Roche, Novartis and Merck & Co....
...Mr Morrison acknowledges that so-called cancer immunotherapy is shaping up to be fiercely competitive, with AstraZeneca trailing Bristol-Myers Squibb, Merck and Roche....
...Top shareholdings: Resolute Forest Products; Dex Media; Cooper Tire & Rubber Company; IBM; Merck & Co; New York Times. Portfolio Value: $2.5bn....
...“It’s a patchwork, with programmes totally at the discretion of the pharmaceutical companies,” says Janet Walton from RxAssist, another clearing house that has seen demand rise by a quarter over the past...
...However, depending on the relative strength of financial markets and the real economy, it might adopt a different exit sequence in the V-shaped recovery scenario, tightening rates before financial market...
...Bad news for leading drug makers Merck and Schering-Plough undercut positive sentiment Monday....
...That case, Altria Group v Good, could determine whether tobacco companies are shielded from lawsuits seeking billions of dollars over the marketing of “light” cigarettes....
...Merck’s shares, up 1.8 per cent after it issued results, trade at 16 times. Volume gains from the companies’ joint venture for blockbuster cholesterol drugs Vytorin and Zetia are tapering....
...It also hired Briggs Morrison from US rival Merck to run Pfizer’s clinical development....
...Manufacturer victories would be good news for an industry smarting from the Vioxx withdrawal, which cost Merck more than $6bn in legal and settlement costs....
...The company faces up to 1,500 lawsuits and federal securities and criminal investigation....
International Edition